GlassScriptPhysician profile
Michael A Samotowka
NPI 1437124021
$526.62
in general payments reported to CMS, 2019-2025
8 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $146 · 2021: $37.82 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $183.95 | 2019-2020 | |
| Baxter Healthcare | $138.65 | 2025 | |
| Z-Medica, LLC | $93.13 | 2020 | |
| Integra Lifesciences Corporation | $37.82 | 2021 | |
| Kerecis Limited | $24.00 | 2020 | |
| Csl Behring | $23.99 | 2019 | |
| Acell, INC. | $13.00 | 2019 | |
| Kls-Martin L.P. | $12.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Samotowka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.